Northwick Park Hospital, UK.
Int J Cardiol. 2010 Apr 15;140(2):169-74. doi: 10.1016/j.ijcard.2008.11.052. Epub 2008 Dec 14.
Following ST elevation acute myocardial infarction (STEMI) and reperfusion therapy, there are often persistent wall thickening (WT) abnormalities and perfusion defects due to variable degree of myocardial stunning and necrosis. We hypothesised that following STEMI and reperfusion therapy, the extent of residual perfusion assessed by myocardial contrast echocardiography (MCE) and not the extent of WT abnormalities would predict subsequent global recovery of left ventricular (LV) function.
Accordingly, 112 patients with STEMI underwent simultaneous assessment of WT abnormality and perfusion using MCE 7+/-2 days after AMI and reperfusion therapy. Both WT and perfusion were scored on a 16 segment LV model. Contrast perfusion index (CPI), and global LV function were calculated. Echocardiography was repeated 12 weeks after reperfusion to assess recovery of LV function.
Of the 112 patients recruited, follow up echocardiography 12 weeks after reperfusion was available in 98 patients. CPI was significantly higher (p<0.0001) in the 66 patients, who showed late recovery of LV function (1.67+/-0.27) compared to those who did not show recovery of function (1.25+/-0.04). No significant difference was noted in the indices of baseline LV function in patients with (1.67+/-0.32) and without (1.80+/-0.36) recovery of LV function. The multivariable predictors of late recovery of function were MCE (p=0.02), absence of diabetes (p=0.02) and lower peak creatine kinase (p=0.01).
The extent of residual contrast perfusion and not WT abnormalities predicts late recovery of global LV function after acute myocardial infarction and reperfusion therapy.
急性 ST 段抬高心肌梗死(STEMI)及再灌注治疗后,由于心肌顿抑和坏死的程度不同,常存在持续的壁增厚(WT)异常和灌注缺损。我们假设,STEMI 及再灌注治疗后,心肌超声造影(MCE)评估的残留灌注程度而非 WT 异常程度,将预测左心室(LV)功能的后续整体恢复。
因此,112 例 STEMI 患者在 AMI 及再灌注治疗后 7+/-2 天,同时行 WT 异常和灌注的 MCE 评估。采用 16 节段 LV 模型对 WT 和灌注进行评分。计算对比灌注指数(CPI)和整体 LV 功能。再灌注后 12 周行超声心动图复查,以评估 LV 功能恢复情况。
112 例入选患者中,98 例有再灌注后 12 周的随访超声心动图。66 例 LV 功能有晚期恢复的患者(1.67+/-0.27)的 CPI 显著高于(p<0.0001)无功能恢复的患者(1.25+/-0.04)。LV 功能恢复患者(1.67+/-0.32)和无功能恢复患者(1.80+/-0.36)的基线 LV 功能指标无显著差异。晚期 LV 功能恢复的多变量预测因素为 MCE(p=0.02)、无糖尿病(p=0.02)和较低的峰值肌酸激酶(p=0.01)。
急性心肌梗死及再灌注治疗后,残留对比灌注程度而非 WT 异常,预测 LV 功能的晚期整体恢复。